Trade ETON stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Eton Pharmaceuticals, Inc. (ETON) is trading at US$50.31, down 1.99% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$1.81B. Over the past 52 weeks, ETON has traded between US$14.27 and US$66.37. On Syfe you can trade ETON with $0 commission and add it to your watchlist.
| Previous close | US$51.33 |
|---|---|
| Market cap | US$1.81B |
| P/E ratio | 26.77 |
| 52-week range | US$14.27 – US$66.37 |
| Volume | 463.23K |
| Exchange | US |
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
Year: 2018
Eton Pharmaceuticals Insider Sold Shares Worth $2,953,572, According to a Recent SEC Filing
Aug 28, 8:56 PM · MT Newswires
Eton Pharmaceuticals Insider Sold Shares Worth $1,626,750, According to a Recent SEC Filing
Aug 24, 9:21 PM · MT Newswires
Eton Pharmaceuticals, Inc. (ETON) stock is trading at US$50.31, -1.99% from the previous close of US$51.33.
The market cap for Eton Pharmaceuticals, Inc. (ETON) stock is approximately US$1.81B.
The price-to-earnings ratio for Eton Pharmaceuticals, Inc. (ETON) is 26.77, based on the latest reported earnings.
The 52-week high for Eton Pharmaceuticals, Inc. (ETON) stock is US$66.37.
The 52-week low for Eton Pharmaceuticals, Inc. (ETON) stock is US$14.27.
Eton Pharmaceuticals, Inc. (ETON) does not currently pay a dividend.
Stay on top of ETON
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
